First Bard Vein Filter Bellwether Heads To Jury
A Phoenix federal jury began deliberations Thursday in the first bellwether trial in multidistrict litigation over claims that device maker Bard's clot-stopping vein implants splintered and migrated towards patients' hearts, after...To view the full article, register now.
Already a subscriber? Click here to view full article